Stay updated on Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi
Sign up to get notified when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.

Latest updates to the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page
- Check4 days agoChange DetectedThe new screenshot shows only minor cosmetic/UI adjustments to the Study Details page, with no changes to core data such as eligibility criteria, primary/secondary outcomes, enrollment, or location. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded an operational status notice and updated version to v3.2.0; removed the old version v3.1.0.SummaryDifference1%

- Check33 days agoChange DetectedAdded revision label v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older revision note v3.0.2.SummaryDifference0.2%

- Check47 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 with removal of the 'Back to Top' link; no substantive content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility locations across various countries and the removal of outdated location information. Additionally, the revision number has been updated, indicating a new version of the content.SummaryDifference4%

Stay in the know with updates to Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Osi+Sav in EGFRm+/MET+ NSCLC Post-Osi page.